These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11528386)

  • 1. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
    Barcellos LF; Caillier S; Dragone L; Elder M; Vittinghoff E; Bucher P; Lincoln RR; Pericak-Vance M; Haines JL; Weiss A; Hauser SL; Oksenberg JR
    Nat Genet; 2001 Sep; 29(1):23-4. PubMed ID: 11528386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point mutation in PTPRC is associated with the development of multiple sclerosis.
    Jacobsen M; Schweer D; Ziegler A; Gaber R; Schock S; Schwinzer R; Wonigeit K; Lindert RB; Kantarci O; Schaefer-Klein J; Schipper HI; Oertel WH; Heidenreich F; Weinshenker BG; Sommer N; Hemmer B
    Nat Genet; 2000 Dec; 26(4):495-9. PubMed ID: 11101853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
    Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
    Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?
    Vorechovsky I; Kralovicova J; Tchilian E; Masterman T; Zhang Z; Ferry B; Misbah S; Chapel H; Webster D; Hellgren D; Anvret M; Hillert J; Hammarstrom L; Beverley PC
    Nat Genet; 2001 Sep; 29(1):22-3. PubMed ID: 11548742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule.
    Jacobsen M; Hoffmann S; Cepok S; Stei S; Ziegler A; Sommer N; Hemmer B
    Immunogenetics; 2002 Jun; 54(3):158-63. PubMed ID: 12073144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.
    Thude H; Rosenhahn S; Hunger-Dathe W; Müller UA; Barz D
    Eur J Immunogenet; 2004 Dec; 31(6):245-7. PubMed ID: 15548260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45 (PTPRC) as a candidate gene in multiple sclerosis.
    Vyshkina T; Leist TP; Shugart YY; Kalman B
    Mult Scler; 2004 Dec; 10(6):614-7. PubMed ID: 15584483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy.
    Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D
    Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population.
    Thude H; Weissenborn S; Vilser C; Müller UA; Kloos C; Wolf G; Beck J; Barz D
    Hum Immunol; 2010 Feb; 71(2):220-3. PubMed ID: 19879912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
    Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
    Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.
    Cocco E; Murru MR; Melis C; Schirru L; Solla E; Lai M; Rolesu M; Marrosu MG
    J Neurol; 2004 Sep; 251(9):1085-8. PubMed ID: 15372250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.
    Vogel A; Strassburg CP; Manns MP
    Genes Immun; 2003 Jan; 4(1):79-81. PubMed ID: 12595907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.
    Kroner A; Mäurer M; Loserth S; Kleinschnitz C; Hemmer B; Rosche B; Toyka KV; Rieckmann P
    Tissue Antigens; 2004 Jul; 64(1):70-3. PubMed ID: 15191525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population.
    Ballerini C; Rosati E; Salvetti M; Ristori G; Cannoni S; Biagioli T; Massacesi L; Sorbi S; Vergelli M
    Neurosci Lett; 2002 Aug; 328(3):325-7. PubMed ID: 12147336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin polymorphisms and disease course in multiple sclerosis.
    Caillier S; Barcellos LF; Baranzini SE; Swerdlin A; Lincoln RR; Steinman L; Martin E; Haines JL; Pericak-Vance M; Hauser SL; Oksenberg JR;
    Genes Immun; 2003 Jun; 4(4):312-5. PubMed ID: 12761568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.
    Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom.
    Nicholas RS; Partridge J; Donn RP; Hawkins C; Boggild MD
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):944-5. PubMed ID: 12810785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis.
    Scalabrini D; Fenoglio C; Scarpini E; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Villa C; Naldi P; Monaco F; Bresolin N; Galimberti D
    Neurosci Lett; 2007 Oct; 425(3):173-6. PubMed ID: 17825989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
    Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
    J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.